DeciBio
Megan Nacar is currently the VP of Commercial at DeciBio, a strategy consulting and market intelligence firm in the precision medicine ecosystem. Prior to this, Megan held positions such as Chief of Staff at Velsera and Pierian, where Megan worked on advancing clinical genomics programs and modernizing patient care. Megan also has a strong background in commercial strategy and sales, with previous roles at QDx Pathology Services, Paycom, and Walgreens. Megan holds a Bachelor of Science (B.S.) degree in Biochemistry from California State University, Fullerton.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.